Method Development and Assessment of the Effects of Tobacco Products on Oral Cavity Cells
NCT ID: NCT01484769
Last Updated: 2017-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2005-07-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of the study is that specific genetic alterations occur in head and neck cancers that have spread to regional and/or distant sites, and these alterations can be identified from biopsy specimens to allow more accurate staging of tumor and better treatment planning.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer
NCT01084733
Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma
NCT02156180
The Effect of Prophylactic Swallowing Exercises on Head and Neck Cancer Patients
NCT01349309
Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer
NCT00527982
Cell-free Tumor DNA in Head and Neck Cancer Patients
NCT03942380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific aims of this study are to compare gene expression between head and neck tumors with and without regional lymph node metastases, and to compare gene expression between head and neck tumor with and without distant metastases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Louisville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kosair Children's Hospital
Louisville, Kentucky, United States
Norton Hospital
Louisville, Kentucky, United States
University of Louisville
Louisville, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
360.05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.